MetaCap

Medpace Statistics

NASDAQ: MEDPHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD

594.75-9.51 (-1.57%)

Market open · Delayed 15 min · as of Oct 8, 1:01 PM ET

Medpace by the numbers

Medpace has a market capitalization of $16.60 billion based on 27.91M shares outstanding. Its trailing P/E ratio is 34.9, below the 3-company peer median of 85.2, and its forward P/E is 30.8. The stock trades 1.1% below its 50-day average and 13.4% above its 200-day average.

Average daily trading volume is 275.31K shares, or about $163.7 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

MEDP valuation vs. peer median

MEDP compared with the median of 8 peer companies
MetricMEDPPeer medianDifference
Market cap$16.60B$1.09B+1417%
P/E (TTM)34.985.2-59%
Forward P/E30.816.6+86%
Avg. volume275.31K881.34K-69%

Peer median across 8 companies: CRL, ICLR, INCY, ABSI, OABI, NRC, MXCT, ONMD.

Valuation

Market cap
$16.60B
Price / sales (latest FY)
6.56
EPS (TTM)
$17.03

Price and trading

Previous close
604.25
Open
602.43
Day range
590.46 – 604.56
52-week range
373.00 – 677.90
52-week change
+13.61%
Beta
—
Volume
78.22K

Dividends and events

Annual dividend
None
Next earnings date
Oct 21, 2026

Additional statistics

Market Cap
16.60B
Pe
34.92
Forward Pe
30.79
Eps
17.03
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
677.90
Week52 Low
373.00
Avg Volume
275.31K
Shares Outstanding
27.91M
Ma50
601.46
Ma200
524.57
Earnings Date
Oct 21, 2026
Pct From52w High
-12.27%
Pct From52w Low
59.45%

Related